• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Inventages Venture Capital Investment Inc.

edit

Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals, enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.

Recent Milestones

edit

• 
  Inventages Venture Capital Investment Inc. invested in Phagenesis. (5/22/13)
  Posted 5/22/13 at 7:34pm via finsmes.com
• 
  Inventages Venture Capital Investment Inc. invested in Phosphate Therapeutics. (3/5/12)
  Posted 3/5/12 at 7:23pm via finsmes.com
• 
  Inventages Venture Capital Investment Inc. invested in Phagenesis. (10/4/11)
  Posted 10/4/11 at 6:28pm via finsmes.com
• 
  Inventages Venture Capital Investment Inc. invested in MSI Methylation Sciences. (9/29/11)
  Posted 9/29/11 at 5:45pm via finsmes.com
• 
  Inventages Venture Capital Investment Inc. invested in Shield Therapeutics. (6/1/11)
  Posted 6/1/11 at 7:36pm via shieldtherapeutics.com
• 
  Inventages Venture Capital Investment Inc. invested in CMP Therapeutics. (7/29/10)
  Posted 8/4/10 at 6:38pm via cmptherapeutics.com
• 
  Inventages Venture Capital Investment Inc. invested in Tanfield Direct Ltd.. (1/25/10)
  Posted 1/22/10 at 4:02pm via dowjones.com
• 
  Inventages Venture Capital Investment Inc. invested in MooBella. (9/18/09)
  Posted 9/19/09 at 4:42am via freshnews.com
• 
  Inventages Venture Capital Investment Inc. invested in Opsona. (6/16/09)
  Posted 6/16/09 at 8:07am via onbiovc.com
• 
  Inventages Venture Capital Investment Inc. invested in Accera. (11/12/08)
  Posted 6/23/09 at 12:01pm via fiercebiotech.com
• 
  Inventages Venture Capital Investment Inc. invested in Food Quality Sensor International. (8/27/07)
  Posted 3/22/10 at 12:43am via findarticles.com
• 
  Inventages Venture Capital Investment Inc. invested in DiObex. (4/16/07)
  Posted 9/16/09 at 7:45am via venturebeat.com
• 
  Inventages Venture Capital Investment Inc. invested in Technologie BiolActis. (2/7/06)
  Posted 4/23/10 at 10:56pm via biolactis.com
• 
  Inventages Venture Capital Investment Inc. invested in DNage. (4/13/05)
  Posted 9/1/10 at 5:22am
• 
  Inventages Venture Capital Investment Inc. invested in Cavis microcaps. (2/3/05)
  Posted 8/27/10 at 4:28am via ecnext.com

Investments

Videos

Sources

1. Phagenesis Extends Series B Financing to $17M (finsmes.com) [edit]
2. Phosphate Therapeutics Raises up to €10.5M in Funding from Inventages Venture Capital (finsmes.com) [edit]
3. Phagenesis Closes €7M Series B Funding Round (finsmes.com) [edit]
4. MSI Methylation Sciences Raises €13.5M in Series A Financing (finsmes.com) [edit]
5. Shield Therapeutics Raises 8.2 million (shieldtherapeutics.com) [edit]
6. CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO (cmptherapeutics.com) [edit]
7. Tanfield Gobbles $6.5M Growth Capital For Natural Foods (fis.dowjones.com) [edit]
8. MOOBELLA, INC. CLOSES $18 MILLION IN SERIES A FUNDING (freshnews.com) [edit]
9. Opsona Therapeutics, Ltd.: Series B $4.6M (onbiovc.com) [edit]
10. Accera raises $35M (fiercebiotech.com) [edit]
11. Food Quality Sensor International Inc. Secures $5.6 Million Financing through European Syndication (findarticles.com) [edit]
12. DiObex, a metabolic disease treatment co., raises $24M (deals.venturebeat.com) [edit]
13. $10 million funding for Biolactis (biolactis.com) [edit]
14. EDGAR [edit]
15. BASF Venture Capital invests in novel encapsulation technology. (goliath.ecnext.com) [edit]